Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Kezar Life Sciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 40 | 39 | −1 |
| Shares | 4.47M | 4.24M | −235.2K (−5.3%) |
| Value | $20.5M | $16.5M | −$3.96M (−19.3%) |
New holders (3)
Institutions that held Kezar Life Sciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bluefin Capital Management, LLC | 33,610 | $131.1K | 0.06% |
| Citadel Advisors LLC | 18,221 | $71.1K | 0.00% |
| Landscape Capital Management, L.L.C. | 13,042 | $50.9K | 0.00% |
Sold out (4)
Institutions that held Kezar Life Sciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Avidity Partners Management LP | 502,600 | $2.30M |
| Sphera Funds Management Ltd. | 58,539 | $268.1K |
| Millennium Management LLC | 25,677 | $117.6K |
| Simplex Trading, LLC | 43 | $0 |